top of page


Published Journal Articles by HBVA Board Members


Tu, T. Stigma: a major barrier to hepatitis B elimination. Nat Rev Gastroenterol Hepatol 19, 622 (2022). 


Lemoh, C., Xiao, Y., Tran, L., Yussf, N., Moro, P., Dutertre, S., & Wallace, J. (2023). An Intersectional Approach to Hepatitis B. International Journal of Environmental Research and Public Health, 20(6), 4879. 


Tran, L. & Cowie, B. C. (2023). Universal testing for hepatitis B must be accompanied by better linkage with care. MEDICAL JOURNAL OF AUSTRALIA, 218(4), pp. 165-166. 


Howell, J., Seaman, C., Wallace, J., Xiao, Y., Scott, N., Davies, J., ... Tu, T., Revill, P., & Hellard, M. E. (2023). Pathway to global elimination of hepatitis B: HBV cure is just the first step. Hepatology (Baltimore, Md.).


Yussf, N., Allard, N., Romero, N., Wilson, A., Wallace, J., Perrier, M., ... & Cowie, B. (2023). Mapping the delivery of interventions for vaccine-preventable infections in pregnancy in Victoria, Australia. Australian Journal of Primary Health.


Deng, H. M. A., Romero, N., Allard, N., Rowe, S., Yussf, N., & Cowie, B. (2023). Uptake of perinatal immunoprophylaxis for infants born to women with a record of hepatitis B in Victoria (2009–2017). Vaccine, 41(10), 1726-1734.


Yussf, N., Wallace, J., Perrier, M., Romero, N., Cowie, B., & Allard, N. (2022). Women with hepatitis B: how mothers with chronic hepatitis B understand and experience the prevention of mother-to-child transmission interventions in Victoria, Australia. Australian Journal of Primary Health, 28(6), 514-521.


Chen, J., Tu, T., Cohen, C., Wang, S., Hsu, Y. C., & Gish, R. G. (2023). Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?. Hepatology, 10-1097.


Tu, T. (2024). Treating People, not just a Virus: Cure, Community, & Collaboration for Hep B. AQ: Australian Quarterly, 95(1), 27–33.

bottom of page